Sort
23,748 grants matching “melanoma”
The role of RB in the retina & other tissues
$368,980James W Harbour · Washington University · R01 · FY2009 · EY
Project 2: Mechanochemical Mechanisms and Vulnerabilities of Individual and Collective Organ-Preferential Metastasis In Vivo
$368,959Peter Friedl · Massachusetts Institute Of Technology · U54 · FY2022 · CA
Targeting apoptosis via chemical design of Bcl-2 antagonists
$368,938Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
Core 1: Biospecimen and Data Management Core
$368,934John B Sunwoo · Stanford University · U54 · FY2016 · CA
Adhesive Signaling by Platelet Integrins
$368,900Sanford J Shattil · University Of California, San Diego · R01 · FY2013 · HL
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
$368,899Jinming Gao · Ut Southwestern Medical Center · R01 · FY2022 · CA
Cancer biology in the zebrafish
$368,865Leonard I Zon · Boston Children'S Hospital · R01 · FY2013 · CA
Functional precision approaches to overcome intrinsic and acquired drug resistance in melanoma
$368,862Jessie Villanueva · Wistar Institute · U54 · FY2025 · CA
Developing therapeutic strategies for ERK-dependent tumors
$368,728Neal Rosen · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Selective Targeting Survivin for Cancer Therapy
$368,723Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2019 · CA
Mechanisms of UV-Mediated Melanoma Development
$368,708Christin E Burd · Ohio State University · R01 · FY2020 · CA
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
$368,628Chrystal Mary Paulos · Emory University · R01 · FY2020 · CA
IDENTIFICATION OF MELANOMA PREDISPOSITION LOCI
$368,622Lisa A. Cannon Albright · University Of Utah · R01 · FY2006 · CA
Role of H11 kinase in cardiac cell growth
$368,605Christophe Depre · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2007 · HL
Novel Therapeutics Targeting INPP5A Pathway in Squamous Cell Carcinoma
$368,536Aleksandar None Sekulic · Mayo Clinic Arizona · R01 · FY2014 · CA
THERAPEUTIC INTERVENTION FOR THE TREATMENT OF RELAPSING MELANOMA
$368,400University Of Maryland, Baltimore · · FY2012 · Department of the Army
Differential role of different NAD+ kinase Isoforms in melanoma metastasis
$368,346Elena Piskounova · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Mechanisms of Lymphatic Metastasis in Melanoma
$368,323Mihaela Skobe · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Edmund K. Moon · University Of Pennsylvania · R01 · FY2017 · CA
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$368,288Arnold I. Caplan · Case Western Reserve University · R01 · FY2021 · CA
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$368,288Arnold I. Caplan · Case Western Reserve University · R01 · FY2020 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Steven Mark Albelda · University Of Pennsylvania · R01 · FY2021 · CA
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$368,288Edmund K. Moon · University Of Pennsylvania · R01 · FY2020 · CA
Innate immunity in dermal fibrosis and systemic sclerosis
$368,251Robert A Lafyatis · Boston University Medical Campus · R01 · FY2012 · AR
Antigenic determinants on HLA-B7 and-A2
$368,221University Of Virginia Charlottesville · R01 · FY2002 · AI